[Translation] Evaluation of the efficacy and safety of HB0034 in patients with acute exacerbations of moderate to severe generalized pustular psoriasis
A multicenter, double-blind, randomized, placebo-controlled, phase II clinical trial
主要(疗效)终点:第 1 周(D8)泛发性脓疱型银屑病医师总体评估(GPPGA)脓疱亚项达 0/1 分(无/几
乎无可见脓疱)受试者比例(%)。
[Translation] Primary (efficacy) endpoint: Generalized pustular psoriasis physician global assessment (GPPGA) pustular subcategory 0/1 (none/several) at week 1 (D8)
Almost no visible pustules) proportion of subjects (%).